Business Description
Life Science REIT PLC
ISIN : GB00BP5X4Q29
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.44 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 7/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate | 79.58 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.75 | |||||
9-Day RSI | 46.71 | |||||
14-Day RSI | 45.49 | |||||
6-1 Month Momentum % | 27.6 | |||||
12-1 Month Momentum % | -28.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.19 | |||||
Dividend Payout Ratio | 5 | |||||
Forward Dividend Yield % | 5.19 | |||||
5-Year Yield-on-Cost % | 5.19 | |||||
Shareholder Yield % | -0.7 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 116.37 | |||||
FCF Margin % | 52.74 | |||||
ROE % | -13.88 | |||||
ROA % | -9.6 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 19.25 | |||||
PE Ratio without NRI | 95 | |||||
PB Ratio | 0.5 | |||||
Price-to-Tangible-Book | 0.5 | |||||
Price-to-Operating-Cash-Flow | 11.17 | |||||
EV-to-Revenue | -6.99 | |||||
EV-to-FCF | -13.32 | |||||
Price-to-Graham-Number | 1.47 | |||||
FCF Yield % | -13.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Life Science REIT PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | -34.407 | ||
EPS (TTM) (£) | -0.114 | ||
Beta | 0.29 | ||
Volatility % | 38.46 | ||
14-Day RSI | 45.49 | ||
14-Day ATR (£) | 0.01108 | ||
20-Day SMA (£) | 0.3858 | ||
12-1 Month Momentum % | -28.09 | ||
52-Week Range (£) | 0.313 - 0.65 | ||
Shares Outstanding (Mil) | 350 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Life Science REIT PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Life Science REIT PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
Life Science REIT PLC Frequently Asked Questions
What is Life Science REIT PLC(LSE:LABS)'s stock price today?
When is next earnings date of Life Science REIT PLC(LSE:LABS)?
Does Life Science REIT PLC(LSE:LABS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |